Histone deacetylase inhibitor AR-42 differentially affects cell cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth

Meningiomas constitute ~34% of primary intracranial tumors and are associated with increased mortality in NF2 patients. To evaluate potential medical therapies for these tumors, we have established a quantifiable orthotopic model for NF2-deficient meningiomas. We showed that telomerase-immortalized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burns, Sarah S., Akhmametyeva, Elena M., Oblinger, Janet L., Bush, Matthew L., Huang, Jie, Senner, Volker, Chen, Ching-Shih, Jacob, Abraham, Welling, D. Bradley, Chang, Long-Sheng
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3549000/
https://ncbi.nlm.nih.gov/pubmed/23151902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-1888
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados